HEALTHY EXTRACTS INC. (HYEX) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
7375 COMMERCIAL WAY HENDERSON, NV 89011 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 66 | 222 | 59 | 133 | 0 | 82 | |||
| Cash and cash equivalents | 66 | 222 | 59 | 133 | 0 | 82 | |||
| Receivables | 106 | 133 | 13 | 26 | 79 | 95 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,819 | 1,958 | 2,418 | 3,081 | 1 | 48 | |||
| Inventory | 1,819 | 1,958 | 2,418 | 3,081 | 1 | 48 | |||
| Other undisclosed current assets | (0) | 0 | (75) | 2 | |||||
| Total current assets: | 1,991 | 2,313 | 2,490 | 3,241 | 6 | 227 | |||
| Noncurrent Assets | |||||||||
| Intangible assets, net (including goodwill) | 199 | 194 | 199 | 208 | 1 | 844 | |||
| Goodwill | 193 | 193 | 193 | 193 | 842 | ||||
| Intangible assets, net (excluding goodwill) | 6 | 1 | 6 | 15 | 1 | 2 | |||
| Prepaid expense | 53 | ||||||||
| Other undisclosed noncurrent assets | 539 | 522 | 426 | 79 | 52 | ||||
| Total noncurrent assets: | 791 | 716 | 625 | 208 | 80 | 896 | |||
| TOTAL ASSETS: | 2,781 | 3,030 | 3,115 | 3,450 | 86 | 1,123 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 186 | 110 | 76 | 124 | 141 | 91 | |||
| Interest and dividends payable | ✕ | ✕ | 13 | 2 | 50 | 84 | 24 | ||
| Accounts payable | 91 | 37 | 65 | 21 | 57 | 67 | |||
| Accrued liabilities | 95 | 59 | 9 | 53 | |||||
| Debt | 275 | 172 | 7 | 80 | 63 | 317 | |||
| Due to related parties | 171 | 171 | 1,051 | 15 | 60 | ||||
| Other undisclosed current liabilities | 442 | 107 | 8 | 3,060 | 3,431 | 1,834 | |||
| Total current liabilities: | 903 | 559 | 262 | 4,315 | 3,650 | 2,302 | |||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 903 | 559 | 262 | 4,315 | 3,650 | 2,302 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 1,878 | 2,471 | 2,854 | (866) | (3,564) | (1,179) | |||
| Preferred stock | 1 | 1 | |||||||
| Common stock | 345 | 338 | 309 | 122 | 6 | 225 | |||
| Additional paid in capital | 17,460 | 17,076 | 15,501 | 9,543 | 7,441 | 6,278 | |||
| Accumulated deficit | (15,927) | (14,944) | (12,956) | (10,530) | (11,013) | (7,683) | |||
| Other undisclosed equity, attributable to parent | 0 | 0 | |||||||
| Total equity: | 1,878 | 2,471 | 2,854 | (866) | (3,564) | (1,179) | |||
| Other undisclosed liabilities and equity | |||||||||
| TOTAL LIABILITIES AND EQUITY: | 2,781 | 3,030 | 3,115 | 3,450 | 86 | 1,123 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,251 | 1,677 | 1,277 | 748 | 67 | 128 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 128 | |
| Sales-type lease, revenue | 2,251 | ✕ | ✕ | |||||
| Other operating income | (98) | (523) | 1,573 | 2,816 | ||||
| Cost of revenue | (880) | (771) | (1,855) | (524) | (29) | (44) | ||
| Cost of goods and services sold | (783) | (346) | (1,892) | |||||
| Other undisclosed gross profit | (0) | (211) | (0) | |||||
| Gross profit: | 1,372 | 695 | (578) | 224 | 39 | 84 | ||
| Operating expenses | (2,283) | (2,584) | (1,475) | (1,164) | (546) | (952) | ||
| Other undisclosed operating loss | (2,816) | |||||||
| Operating loss: | (912) | (1,889) | (2,053) | (940) | (3,323) | (867) | ||
| Nonoperating expense (Other Nonoperating expense) | (72) | |||||||
| Interest and debt expense | 47 | 53 | 526 | (171) | ||||
| Loss from continuing operations before income taxes: | (983) | (1,889) | (2,006) | (887) | (2,797) | (1,038) | ||
| Other undisclosed income (loss) from continuing operations | (87) | 1,520 | ||||||
| Income (loss) from continuing operations: | (983) | (1,976) | (2,006) | 633 | (2,797) | (1,038) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (1,976) | (2,006) | 633 | (2,803) | (1,038) | ||
| Loss from discontinued operations | (6) | |||||||
| Other undisclosed net loss | (11) | (570) | (2,524) | |||||
| Net income (loss): | (983) | (1,987) | (2,576) | 633 | (2,803) | (3,562) | ||
| Other undisclosed net loss attributable to parent | (526) | |||||||
| Net income (loss) available to common stockholders, diluted: | (983) | (1,987) | (2,576) | 633 | (3,330) | (3,562) | ||
Comprehensive Income ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (983) | (1,987) | (2,576) | 633 | (2,803) | (3,562) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (983) | (1,987) | (2,576) | 633 | (2,803) | (3,562) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.